Complications from use of sodium hyaluronate (Healonid) in anterior segment surgery

Abstract

Sodium hyaluronate brings an important new advance to several techniques in ophthalmic microsurgery. Its use in 226 primary lens implantations is described, and it has been found to be safe and beneficial to both surgeon and patient. Apart from a one day rise of intraocular pressure, obviated by the routine use of timolol maleate or acetazolamide, it has been found in the dosage used to be free from complication.